Healthwell Acquisition Corp. I
HWEL
NASDAQ Capital Market10.48
USD
+0.01
- -
CIK
0001845013
ISIN
US42227R1095
CUSIP
42227R109
Return %
Stock
S&P500
1Y
5.81
18.02
3Y
8.77
64.11
5Y
8.77
72.15
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Alyssa J. Rapp
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1001 Green Bay Road Winnetka IL United States of America 60093
- IPO Date
- Sep 23, 2021
- CIK
- 0001845013
- Website
- healthwellspac.com
- Similar Companies
- Business
- Healthwell Acquisition Corp. I Healthwell Acquisition Corp. I is a blank check company, also known as a special purpose acquisition company or SPAC, whose principal business activity involves seeking to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities; it currently conducts no significant operations and generates no revenues. The company targets technology-enabled companies across the healthcare industry, including sectors such as therapeutics, diagnostics, and digital health solutions, with a focus on entities offering innovative platforms for patient care, drug delivery systems, or AI-driven healthcare services. Incorporated in 2021 and headquartered in Winnetka, Illinois, Healthwell Acquisition Corp. I operates as a subsidiary of Healthwell Acquisition Corp. I Sponsor LLC and maintains its geographic focus primarily within the United States. In a significant recent development, the company terminated its previously announced business combination agreement with Starton Therapeutics Inc. in November 2023 after the outside closing date passed without satisfaction of required conditions, leading to the subsequent cancellation of a special stockholder meeting, redemption of all outstanding public shares at approximately $10.50 per share, and initiation of liquidation and dissolution proceedings as of late 2023, with public shares cancelled by December 2023 and warrants expiring worthless.
Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate
Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.
Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I
Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions
Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions